(Q40442992)

20 September 2017

1 reference

title

Diltiazem: ten years of clinical experience in the treatment of hypertension (English)

1 reference

20 September 2017

Diltiazem: Ten Years of Clinical Experience in the Treatment of Hypertension (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

13 June 2024

author name string

M. R. Weir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608309

13 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7608309

13 June 2024

publication date

1 March 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1995.tb04051.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/j.1552-4604.1995.tb04051.x

13 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

The Journal of Clinical Pharmacology

13 June 2024

published in

1 reference

20 September 2017

volume

35

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

220-232

1 reference

Cellular calcium in ischemic acute renal failure: role of calcium entry blockers

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of diltiazem on hormonal and hemodynamic responses to lower body negative pressure and tilt in patients with mild to moderate systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Multiple effects of calcium entry blockers on renal function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Determinants of left ventricular hypertrophy and function in hypertensive patients. An echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Pharmacologic management of systemic hypertension in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Comparison of diltiazem and atenolol in young, physically active men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Physiologic and hemodynamic considerations in blood pressure control while maintaining organ perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

The effects of antihypertensive therapy on the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

A comparison of verapamil and nifedipine on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04051.X

History of calcium antagonists

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

The pharmacokinetics of diltiazem in healthy American men

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Diltiazem Inhibits the Spontaneous Platelet Aggregation in Essential Hypertension

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Endocrine and vascular responses in hypertensive patients to long-term treatment with diltiazem

13 June 2024

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Effects of diltiazem hydrochloride on cardiovascular response, platelet aggregation and coagulating activity during exercise testing in systemic hypertension.

13 June 2024

14

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Efficacy, electrocardiographic and renal effects of intravenous diltiazem for essential hypertension

13 June 2024

19

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Long-term renal effects of diltiazem in essential hypertension

13 June 2024

21

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Comparative effects of propranolol and diltiazem on systolic and diastolic left ventricular function in essential hypertension

13 June 2024

23

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension

13 June 2024

24

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

ECG-gated cardiac scan and echocardiographic assessments of left ventricular hypertrophy: reversal by 6-month treatment with diltiazem

13 June 2024

27

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals

13 June 2024

29

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension

13 June 2024

30

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

BP as a Determinant of Cardiac Left Ventricular Muscle Mass

13 June 2024

32

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

The heart in hypertension

13 June 2024

34

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Regression of myocardial hypertrophy and influence of adrenergic system

13 June 2024

35

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Cardiac and vascular actions of decapeptide angiotensin analogs

13 June 2024

36

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Ambulatory blood pressure variation is related to plasma renin activity in borderline hypertensive men

13 June 2024

37

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Comparison of diltiazem and hydrochlorothiazide for treatment of patients 60 years of age or older with systemic hypertension

13 June 2024

43

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension

13 June 2024

47

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity

13 June 2024

50

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins

13 June 2024

52

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women

13 June 2024

53

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Individual responses to converting enzyme inhibitors and calcium antagonists

13 June 2024

54

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension

13 June 2024

55

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Antihypertensive and metabolic effects of diltiazem and nifedipine

13 June 2024

59

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol

13 June 2024

64

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Comparison of blood pressure response to heat stress in sauna in young hypertensive patients treated with atenolol and diltiazem

13 June 2024

65

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial

13 June 2024

66

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Prevalence and natural history of electrocardiographic left ventricular hypertrophy

13 June 2024

71

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Reversibility of left ventricular hypertrophy

13 June 2024

73

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension

13 June 2024

75

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study

13 June 2024

76

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Calcium channel blocking drugs for chronic, stable angina. Diltiazem

13 June 2024

77

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study

13 June 2024

85

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

13 June 2024

89

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

13 June 2024

93

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.

13 June 2024

94

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring

13 June 2024

95

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol

13 June 2024

99

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Individual responses to converting enzyme inhibitors and calcium antagonists

13 June 2024

100

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Antihypertensive treatment and serum lipoproteins

13 June 2024

101

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Antihypertensive therapy and lipids. Evidence, mechanisms, and implications

13 June 2024

102

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial

13 June 2024

103

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

Pharmacokinetic Properties and Antihypertensive Efficacy of Once-Daily Diltiazem

13 June 2024

109

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

A dose-response trial of once-daily diltiazem

13 June 2024

112

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04051.X

13 June 2024

Identifiers

1 reference

20 September 2017

1 reference